Cargando…
A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome
INTRODUCTION: Genetic profile studies of breast cancer identified a number of biologically different subtypes. These genetic subtypes are often surrogated by oestrogen receptors (ERs), progesterone receptors (PR) and HER2 status as measured by immunohistochemistry (IHC). Triple negative (TN) subtype...
Autores principales: | Zekri, J M, Ibrahim, E, Ben Sadiq, B, Al-Gahmi, AM, Zeeneldin, AA, Elkhodary, TR, Gaballa, HE, Fawzy, EE, Elsayed, ME, Bahadur, Y, Awadalla, S, Alzahran, MS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234014/ https://www.ncbi.nlm.nih.gov/pubmed/22276028 http://dx.doi.org/10.3332/ecancer.2010.167 |
Ejemplares similares
-
Pre-operative systemic therapy in locally advanced breast cancer: a single institution experience
por: Ibrahim, EM, et al.
Publicado: (2009) -
Past, Present and Future of Colorectal Cancer in the Kingdom of Saudi Arabia
por: Ibrahim, Ezzeldin M., et al.
Publicado: (2008) -
Cardiac function in women receiving dual anti-Her2 antibodies (trastuzumab and pertuzumab) combined with chemotherapy for breast cancer
por: Zekri, Jamal, et al.
Publicado: (2023) -
Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome
por: Tso, For Yue, et al.
Publicado: (2018) -
Capecitabine-induced terminal ileitis
por: Al-Gahmi, Aboelkhair Mohammad, et al.
Publicado: (2012)